Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells

scientific article

Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00005392-200102000-00083
P698PubMed publication ID11176447

P2093author name stringMiyajima A
Asano T
Hayakawa M
P2860cites workInactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instabilityQ24319995
Mechanism of activation of the TGF-beta receptorQ28245861
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)616-620
P577publication date2001-02-01
P1433published inJournal of UrologyQ15709979
P1476titleCaptopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells
P478volume165

Reverse relations

cites work (P2860)
Q37741923Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling
Q29010479Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy
Q38997782Evidence for aldosterone-dependent growth of renal cell carcinoma
Q54378816Insertion/deletion polymorphism of angiotensin I-converting enzyme gene is linked with chromophobe renal cell carcinoma.
Q73366506Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma
Q35653603Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal

Search more.